Peer-influenced content. Sources you trust. No registration required. This is HCN.
Renal & Urology News
New research reveals significant differences in overall survival rates based on the site of visceral metastases in metastatic prostate cancer. Discover how these insights could shape your approach to patient care.
Oncology, Radiation September 5th 2023
The New England Journal of Medicine
Learn how CRISPR-Cas9 gene editing holds the promise of elevating fetal hemoglobin levels and significantly reducing sickle cell disease manifestations. Explore the study’s findings to consider this potential game-changer for your practice.
Hematology September 5th 2023
Journal of Pharmacy Practice (JPP)
Sugammadex is a safe and effective medication that can be used to reverse rocuronium-induced paralysis and facilitate neurologic examination in patients with neurologic injuries. Pharmacists can play a role in ensuring that patients receive the appropriate dose of sugammadex and that it is administered in a timely manner.
Clinical Pharmacology August 31st 2023
ACP Internist
A recent study found that patients who used proton pump inhibitors (PPIs) for more than 4.4 years had a 33% higher risk of developing dementia during the follow-up period.
Annals of Internal Medicine
The study reveals that generic Wixela Inhub is comparable to Advair Diskus in both effectiveness and safety for treating COPD. Consider this cost-effective alternative in your treatment plans.
American Journal of Endocannabinoid Medicine (AJEM)
This longitudinal study offers valuable insights into the complex effects of medical cannabis on quality of life in anxiety patients. Physicians may find the nuanced findings on mental and physical well-being particularly relevant for treatment considerations.
Family Medicine/General Practice August 30th 2023